Topamax
NDC 50458-642, topiramate, tablet, coated, from Janssen Pharmaceuticals, Inc..
- Product NDC
- 50458-642
- Status
- Listed
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020505
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50458-642 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE200 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50458-642-65 | 50458064265 | 60 TABLET, COATED in 1 BOTTLE (50458-642-65) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/21628112-0c47-11df-95b3-498d55d89593NADAC price for package 50458064265
GET /v1/drugs/nadac/50458064265
Use it
Look up 50458-642 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50458-642 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50458-642. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.